Trial Profile
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs HP 802247 (Primary)
- Indications Leg ulcer; Varicose ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Smith & Nephew Biotherapeutics
- 30 Sep 2014 New trial record